Simulations Plus, Inc.
NASDAQ:SLPMedical - Healthcare Information Services
+$0.02 today
- Market cap
- $374.16M
- Beta
- 1.32
- P/E (TTM)
- -5.9
- EPS (TTM)
- -$3.12
Volume 0.00M
Average 0.35M
SLP Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
Simulations Plus, Inc.NASDAQ: SLP
Capital Expenditures · Q2 FY2026 · quarter ended Feb 2026
Capital expenditures declines year over year
Q2 FY2026 capital expenditures of $46K (cash outflow) fell 30.3% year over year, behind the -17.8% change in trailing-twelve-month capital expenditures. Sequentially, it fell 94.9% from the prior quarter. Over 3 fiscal years it compounded at -43.6% a year.
Context
- Capital expenditures amounted to 0.9% of revenue in FY2025, unchanged from a year earlier.
- Capital expenditures grew in size in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from -30.3% toward the trailing-twelve-month pace of -17.8%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
USD · from the cash flow
- Latest · FY2025
- (713K) USD
- Year-over-year change
- -26.0%
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2025 | 2025-08-31 | (713K) | -26.0% |
| FY2024 | 2024-08-31 | (566K) | +86.8% |
| FY2023 | 2023-08-31 | (4.27M) | -7.6% |
| FY2022 | 2022-08-31 | (3.97M) | +13.2% |
| FY2021 | 2021-08-31 | (4.58M) | — |
Capital Expenditures vs competitors
How SLP compares with its peers on the latest reported figures
- Peers report in different currencies, so capital expenditures is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -17.8% is the 3rd highest of 11, against a peer median of -61.0%.
- Capital expenditures amounts to 1.9% of revenue for SLP, versus a peer median of 3.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $26.56M USD | +41.9% | -26.0% | 0.5% | |
| LTM Mar 2026 | $9.55M USD | -33.2% | +2.9% | 6.9% | |
| LTM Mar 2026 | $3.31M USD | -57.1% | -61.9% | 4.1% | |
| LTM Mar 2026 | $2.23M USD | -44.0% | -1.0% | 3.3% | |
| LTM Mar 2026 | $2.22M USD | -88.8% | +26.2% | 0.9% | |
| LTM Feb 2026 | $1.51M USD | -17.8% | -43.6% | 1.9% | |
| LTM Dec 2025 | CHF 900.16K CHF | +56.3% | -11.5% | 25.2% | |
| LTM Mar 2026 | $556K USD | -70.3% | -68.0% | — | |
| LTM Mar 2026 | $420K USD | -96.6% | -53.7% | 10.9% | |
| LTM Mar 2026 | $61.38K USD | -64.9% | -9.6% | 1.6% | |
| LTM Mar 2026 | $52K USD | -84.0% | -38.1% | 0.0% | |
| Peer median (excluding SLP) | — | -61.0% | -18.7% | 3.3% | |
Competitors are the stored peer set for SLP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Aug 2021 | FY2022 Aug 2022 | FY2023 Aug 2023 | FY2024 Aug 2024 | FY2025 Aug 2025 |
|---|---|---|---|---|---|
| Net Income | 9.78M | 12.48M | 9.96M | 9.95M | (64.72M) |
| Depreciation & Amortization | 3.59M | 3.57M | 3.84M | 5.67M | 8.21M |
| Deferred Income Tax | (628K) | (270K) | (2.1M) | (1.77M) | (5.43M) |
| Stock-Based Compensation | 2.75M | 3.04M | 4.83M | 6.54M | 6.35M |
| Change in Working Capital | 974K | (2.62M) | 5.1M | (4.21M) | (2.59M) |
| Accounts Receivables | (2.43M) | (3.94M) | 4.1M | 3.13M | (581K) |
| Inventory | 3.15M | 0 | 0 | 0 | 0 |
| Accounts Payables | 39K | (162K) | (81K) | (477K) | (132K) |
| Other Working Capital | 210K | 1.48M | 1.09M | (6.86M) | (1.87M) |
| Other Non-Cash Items | 2.74M | 1.7M | 219K | (2.86M) | 76.29M |
| Operating Cash Flow | 19.2M | 17.9M | 21.86M | 13.32M | 18.13M |
| Capital Expenditures | (4.58M) | (3.97M) | (4.27M) | (566K) | (713K) |
| Acquisitions (Net) | 2.95M | 3.15M | (8.22M) | (98.77M) | 0 |
| Purchases of Investments | (122.4M) | (100.85M) | (95.05M) | (67.16M) | (6.5M) |
| Sales of Investments | 100.23M | 109.12M | 114.91M | 116.27M | 15.01M |
| Other Investing Activities | (2.95M) | (3.15M) | (3.82M) | (3.74M) | (4.24M) |
| Investing Cash Flow | (26.74M) | 4.31M | 7.37M | (53.97M) | 3.56M |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued | 1.46M | 891K | 0 | 731K | 430K |
| Common Stock Repurchased | 0 | 0 | (20M) | 0 | 0 |
| Dividends Paid | (4.81M) | (4.85M) | (4.81M) | (4.8M) | 0 |
| Other Financing Activities | (1.33M) | (3.67M) | 1.54M | (2.5M) | (1.58M) |
| Financing Cash Flow | (4.68M) | (7.62M) | (23.27M) | (6.57M) | (1.15M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | (12.22M) | 14.58M | 5.96M | (47.21M) | 20.54M |
| Free Cash Flow | 14.63M | 13.93M | 17.58M | 12.75M | 17.41M |
Simulations Plus, Inc.
NASDAQ:SLP
Intrinsic Alpha fair value
Locked
Current Price
$18.50
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.